Hilde Hermansen Steineger
Founder at NorthSea Therapeutics BV
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Kollender | M | 54 |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | 9 years |
| John Johnson | M | 66 |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | 9 years |
| Hilde Furberg | F | 65 |
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | 8 years |
| A. Davis | M | 57 |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | 9 years |
| Alexander Lindström | M | - |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | - |
| Lars Kåre Viksmoen | M | 75 | 13 years | |
| Robert Lutz | M | 55 |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | 8 years |
| Stephen J. Long | M | 58 |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | 9 years |
| Ruth Thieroff-Ekerdt | M | 66 |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | 10 years |
| Hans Peter Bøhn | M | 69 | 9 years | |
| David A. Fraser | M | - |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | - |
| Morris J. Birnbaum | M | 72 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | 2 years |
| Giuditta Cordero-Moss | M | 61 |
University of Oslo
| 28 years |
| Theodore R. Koziol | M | - |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | - |
| Richard Gaster | M | 40 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | 4 years |
| John Kastelein | M | 70 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | - |
| Rob de Ree | M | - |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | - |
| Søren Møller | M | 56 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | - |
| Somu Subramaniam | M | 69 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | - |
| Mats Blom | M | 59 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | 5 years |
| Hugo Slootweg | M | 53 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | 7 years |
| Dirk Kersten | M | 49 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | - |
| Jonathan Leff | M | 66 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | 2 years |
| Jordi Xiol | M | - |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roy Hartvig Larsen | M | 62 | 7 years | |
| Tone Kvåle | F | 55 | 8 years | |
| Malene Brondberg | F | 51 | 5 years | |
| Ludvik Sandnes | M | - | 6 years | |
| Olav Hellebø | M | 59 | 3 years | |
| Gunnar Manum | M | 60 | 8 years | |
| Martin Nes | M | 55 | - | |
| Bjørg Bolstad | F | - | 3 years | |
| Matthew Pauls | M | 53 | 5 years | |
| Garheng Kong | M | 49 | 6 years | |
| Jens Bjørheim | M | - |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway.
University of Oslo
| 10 years |
| Marco Renoldi | M | 67 | 8 years | |
| Göran Gannedahl | M | 71 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | - |
| Peter J. Valentinsson | M | - | - | |
| Camilla Sandberg | F | 57 |
University of Oslo
| 6 years |
| Rainer Boehm | M | 63 | 4 years | |
| Fredrik Haavind | M | - | - | |
| Marten Steen | M | 49 | - | |
| Christina Elisabeth Herder | M | 63 | 8 years | |
| Jan Hendrik Egberts | M | 65 | 4 years | |
| Andrew Hughes | M | - | 5 years | |
| Lars Nieba | M | 56 | - | |
| David Gill | M | 69 | 2 years | |
| Jean Bizzari | M | 69 | - | |
| Stina Margareta Gestrelius | M | 75 | - | |
| Alexandra Morris | F | 62 | 2 years | |
| Gisela Schwab | M | 67 | 5 years | |
| Joanna Horobin | M | 69 | 7 years | |
| Anders Paul Wiklund | M | 84 | 3 years | |
| Jeffrey Sherman | M | 69 | 5 years | |
| Thomas Settevik | M | 64 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | 4 years |
| Robert Spiegel | M | 73 | - | |
| Edward Karol Sikora | M | 76 | - | |
| Per Anders Göte Samuelsson | M | 63 | 8 years | |
| Hans Ivar Robinson | M | 57 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | 2 years |
| Håvard Vikse | M | - |
University of Oslo
| 4 years |
| Gulden Tobias Dahl | M | - |
University of Oslo
| 3 years |
| Kathrine Elisabeth Andreassen | F | 58 | 6 years | |
| Keith McCullagh | M | 80 | - | |
| Nils Arne Grønlie | M | - |
University of Oslo
| 3 years |
| Håvard Hildeng Hauge | M | 55 |
University of Oslo
| 3 years |
| Valborg Godal Vold | F | - | - | |
| Reza Safaei | M | - | - | |
| Haakon Bryhni | M | 56 |
University of Oslo
| 3 years |
| Geir Christian Melen | M | 60 | - | |
| Anita Høst | F | - |
University of Oslo
| 3 years |
| Nils Holger Koefoed | M | - |
University of Oslo
| 1 years |
| Marianne Thorsdal | F | 61 |
University of Oslo
| 4 years |
| Bjørn Petter Lindhom | M | - |
University of Oslo
| 1 years |
| Mark Wright | M | - | - | |
| Peter L. Braun | M | - | - | |
| Christine Wilkinson-Blanc | M | - | 1 years | |
| Anne Kristin Holmeide | M | 56 |
University of Oslo
| 3 years |
| Marianne Langrind Kvanvik | F | 50 |
University of Oslo
| 3 years |
| Bettina Banoun | M | 52 |
University of Oslo
| 3 years |
| Ole Dahlberg | M | - |
University of Oslo
| 1 years |
| Norbert Hoyer | M | - |
University of Oslo
| 3 years |
| Marianne Heien Blystad | F | 66 |
University of Oslo
| 3 years |
| Iacob Mathiesen | M | 57 |
University of Oslo
| 3 years |
| Unni Marie Rådalen | F | 53 |
University of Oslo
| 9 years |
| Karin Judith Meyer-Rosberg | M | 58 | 3 years | |
| Edith Rian | M | 58 |
University of Oslo
| 3 years |
| Jan Alan Alfheim | M | - | 5 years | |
| Solveig Elisabeth Hellebust | M | 57 | 2 years | |
| Adele Bugge Norman Pran | F | 54 |
University of Oslo
| 3 years |
| Henrik Inadomi | M | - |
University of Oslo
| 4 years |
| Athos Gianella-Borradori | M | 70 | - | |
| Christopher William Ihlen | M | 56 |
University of Oslo
| 6 years |
| Thomas Rygg Hannestad | M | 54 |
University of Oslo
| 3 years |
| Daniel Kjørberg Siraj | M | 49 |
University of Oslo
| 3 years |
| May Arna Risberg | M | - |
University of Oslo
| 3 years |
| Mari Rege | M | 50 |
University of Oslo
| 3 years |
| Felix Reimers | M | - |
University of Oslo
| 3 years |
| Randi Haugaa | F | 55 |
University of Oslo
| 6 years |
| Tarik Cicic | M | - |
University of Oslo
| 3 years |
| Bjørn Næss | M | - |
University of Oslo
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 74 | 74.00% |
| Ireland | 12 | 12.00% |
| Netherlands | 12 | 12.00% |
| United States | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hilde Hermansen Steineger
- Personal Network